<--- Back to Details
First PageDocument Content
Eculizumab / Immunosuppressants / Complement deficiency / Alexion Pharmaceuticals / Paroxysmal nocturnal hemoglobinuria / Hemoglobinuria / Hemolytic-uremic syndrome / Medical prescription / Haemophilus influenzae / Health / Medicine / Acquired hemolytic anemia
Date: 2014-12-29 17:37:38
Eculizumab
Immunosuppressants
Complement deficiency
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Hemoglobinuria
Hemolytic-uremic syndrome
Medical prescription
Haemophilus influenzae
Health
Medicine
Acquired hemolytic anemia

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES 1. Requirements for Prior Authorization of Soliris (eculizumab) A.

Add to Reading List

Source URL: www.dhs.state.pa.us

Download Document from Source Website

File Size: 129,28 KB

Share Document on Facebook

Similar Documents

[Product Monograph Template - Schedule D]

[Product Monograph Template - Schedule D]

DocID: 1qWQL - View Document

Microsoft Word - CINRYZE.Product Monographdoc

Microsoft Word - CINRYZE.Product Monographdoc

DocID: 1qE2h - View Document

Microsoft Word - FIRAZYR.Product Monographdoc

Microsoft Word - FIRAZYR.Product Monographdoc

DocID: 1qA9x - View Document

Firazyr, INN-Icatibant acetate

Firazyr, INN-Icatibant acetate

DocID: 1aUNQ - View Document

letters to the editor The opinions expressed by correspondents in this column are in no way endorsed by either the Editors or The Royal Australian College of General Practitioners  ACEI associated

letters to the editor The opinions expressed by correspondents in this column are in no way endorsed by either the Editors or The Royal Australian College of General Practitioners ACEI associated

DocID: 18JVW - View Document